I read this morning in my Women's Parkinson's Project Newsletter the following and found it very interesting. I'm glad to see some research that deals with gender differences in Parkinson's for better treatment options.
The following copied from the above newsletter written by Richelle Flanagan. womensparkinsonsproject.com...
A recent study by Contin et al (2022) looked at the absorption rates of levodopa into the body. They found that women absorbed levodopa 27% more than men.
As a result of this higher absorption rate, women also had higher levels of levodopa-induced dyskinesia. Of note younger people also tend to suffer more from dyskinesia.
Whilst this study did not find body weight as a causative factor for the higher absorption in women, another recent study by Conti et al (2022) found that the body mass index (BMI), was a factor. These authors also suggest other causative factors such as women having a slower rate of gastric emptying and approximately 25% less COMT enzyme (which breaks down levodopa) than men.
Another interesting finding by Contin et al (2022) found a 20% higher absorption of levodopa in patients treated with levodopa/benserazide versus levodopa/carbidopa formulation. These are all important findings for women with Parkinson's. Considering that women seem to suffer more from levodopa-induced dyskinesias which can be very debilitating especially when women are invariably juggling work and family commitments, it would seem unbelievable that there is not more research to develop more personalized, gender-based dosing guidelines. If you are suffering from levodopa-induced dyskinesia you should consider bringing these papers to your neurologist to discuss more individualized levodopa therapy.
pubmed.ncbi.nlm.nih.gov/363... - 1st paper
pubmed.ncbi.nlm.nih.gov/125... -2nd paper